Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gulong Capsule is a traditional Chinese medicine (TCM) developed and manufactured by Dong-E E-Jiao Co., Ltd. It is primarily indicated for the treatment of rheumatoid arthritis, osteoarthritis, and other musculoskeletal conditions characterized by joint pain, swelling, and restricted movement (traditionally described as 'wind-dampness obstruction'). The formulation is a complex mixture of animal-derived and herbal ingredients, including *Pheretima* (earthworm), *Scolopendra* (centipede), *Scorpio* (scorpion), *Drynariae Rhizoma* (Gusuibu), and processed *Aconiti Radix*. These components are traditionally used to 'dredge meridians' and 'dispel wind-dampness.' Modern pharmacological research indicates that Gulong Capsule exerts anti-inflammatory and analgesic effects, likely through the inhibition of pro-inflammatory mediators and improvement of local microcirculation in affected joints.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gulong Capsule.